Clearwater Paper Stock - Analyst and Consensus View on the Specialty Paper Maker

Clearwater Paper stock lacks fresh company news today, but Wall Street’s limited coverage and current earnings expectations still frame the risk-reward profile for the specialty paper producer. Here is how analysts value the stock and what consensus suggests.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/21/2026, 18:33 CET. Details in the imprint.

Clearwater Paper (US18539C2044) currently has no fresh market-moving corporate release or major news from top wire services. Instead, the stock is shaped by a thin analyst base, modest earnings expectations, and its positioning in the North American tissue and paperboard market.

How many analysts cover Clearwater

Clearwater Paper is a small-cap US paper and packaging producer, and Wall Street coverage is relatively sparse compared with larger peers. Market data platforms such as MarketWatch and Yahoo Finance typically show only a handful of active analyst ratings for the stock, often fewer than five at any given time.

This light coverage means that changes in a single analyst model or rating can have a visible impact on consensus earnings and target prices. For investors, it also implies that valuation may adjust more slowly to new company information than in heavily covered large caps.

What current consensus implies

Recent aggregation of estimates on financial portals indicates analysts expect Clearwater Paper to remain profitable, with earnings per share in the low to mid single digits for the current fiscal year, reflecting its exposure to consumer tissue and paperboard demand.

Revenue expectations generally assume mid-single-digit percentage growth or a roughly stable top line, depending on tissue pricing and volume trends. Margin forecasts factor in relatively high input costs for pulp and energy, partially offset by pricing discipline and cost measures.

Rating distribution and target levels

Given the small analyst base, ratings on Clearwater Paper tend to cluster around Hold or Buy, with very few formal Sell recommendations reported on major financial data sites. Where disclosed, 12-month price targets usually imply moderate upside or a fairly valued stock at current levels.

The dispersion of price targets is also narrower than for some higher-growth sectors. That reflects Clearwater’s role as a more traditional manufacturing business with mature end markets rather than a high-volatility growth story.

How consensus has shifted recently

Across recent quarters, consensus earnings for Clearwater Paper have moved mainly in response to pulp price swings, energy costs and observed pricing power in its tissue and paperboard franchises. Analysts adjust models when the company updates its outlook in quarterly calls and presentations.

Compared with the pandemic period, when tissue demand temporarily spiked, current estimates assume more normalized consumption patterns. That means lower volatility in volume assumptions but continued sensitivity to commodity costs and operational efficiency.

The business behind the estimates

Clearwater Paper’s consensus profile is rooted in a fairly straightforward business mix. The company reports two segments: Consumer Products, centered on private-label tissue, and Pulp and Paperboard, which supplies bleached paperboard for packaging and commercial printing.

Investors following consensus trends therefore watch indicators such as private-label tissue share at US retailers, packaging demand in key end markets like food and beverage, and the direction of benchmark pulp prices. These drivers feed into analysts’ revenue and margin expectations.

Why coverage is thinner than peers

Compared with large integrated forest products companies and global packaging groups, Clearwater Paper’s smaller market capitalization and narrower geographic footprint can make the stock less of a priority for major brokerage research desks. That naturally limits the number of published models.

In addition, Clearwater focuses on private-label products rather than widely advertised consumer brands, which can reduce the broader investor marketing profile. The result is a stock that trades on fundamentals but without the constant analyst and media attention seen in larger, brand-heavy peers.

Context from prior filings

Recent Form 10-K and 10-Q filings with the US Securities and Exchange Commission describe Clearwater Paper’s strategy of optimizing its mill footprint, investing selectively in tissue and paperboard assets, and maintaining a disciplined balance sheet. SEC filings provide detailed financial and operational history.

These documents have guided analyst models in the absence of high-frequency corporate news. They spell out capital expenditure plans, debt maturities and key risk factors, from raw material volatility to competition in private-label tissue.

Comparing valuation to peers

Data from financial portals suggests Clearwater Paper often trades at a discount on simple valuation multiples like price-to-earnings or enterprise value to EBITDA compared with larger packaging and tissue peers.

Analysts typically attribute this to smaller scale, customer concentration and more cyclical earnings. At the same time, the company’s focus on private-label tissue and packaging board gives it exposure to relatively resilient end uses, which can help stabilize cash flow through the cycle.

Balance sheet and cash flow lens

Consensus models closely watch net debt and leverage metrics, as capital-intensive paper manufacturing requires ongoing investment. Clearwater Paper has historically prioritized balance-sheet strength, targeting leverage that allows for mill investments while keeping financial flexibility.

Free cash flow expectations in analyst models depend on the timing of maintenance outages, capital projects and working capital swings. In periods of heavy investment, free cash flow can temporarily soften even if EBITDA remains stable.

What could move consensus next

In the absence of today’s specific news, the next key potential catalysts for Clearwater Paper consensus are the upcoming quarterly earnings release and any updates to full-year guidance. Changes in pulp price indices or notable retailer developments in private-label tissue could also prompt estimate revisions.

Moreover, any announced portfolio actions, such as asset sales or targeted capacity expansions, would likely feed into valuation and rating discussions among the small analyst group that follows the stock.

The product behind the stock

Clearwater Paper generates most of its revenue by producing private-label bathroom tissue, paper towels and napkins for North American retailers, alongside bleached paperboard used in folding cartons for consumer goods, beverages and food packaging. Its mills convert pulp into finished tissue rolls and coated paperboard sheets.

Where the stock trades today

Clearwater Paper shares trade on the New York Stock Exchange at around the latest available market price in USD as of the most recent session close, based on consolidated exchange data.

Key facts on Clearwater Paper stock

• Company: Clearwater Paper Corp.
• ISIN: US18539C2044
• WKN: A2QD4K
• Ticker: CLW
• Venue: NYSE
• Price (as of 06/21/2026, 18:33 CET): latest available close USD
• Market cap: latest available figure USD (as of 06/21/2026)
• Sector / Industry: Materials / Paper & Forest Products
• Index membership: not a member of major flagship indices such as the S&P 500 or Nasdaq-100
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.